The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
IL-6-Deficient Mice Are Resistant to Experimental Autoimmune Encephalomyelitis: Roles of IL-6 in the Activation and Differentiation of Autoreactive T Cells
Abstract
Although autoreactive T cells recognizing self myelin Ags are present in most individuals, autoimmune disease of the central nervous system is a relatively rare medical condition. Development of autoimmune disease may require not only the presence of autoreactive T cells but also that autoreactive T cells become activated. Activation of T cells may require a minimum of two signals: an Ag-specific signal delivered by MHC-peptide complex and a second signal delivered by costimulatory molecules or cytokines. Although in vitro studies have suggested that cytokines, especially proinflammatory cytokines such as IL-1, IL-6, and TNF are involved in T cell activation, their precise roles in vivo are not clear. To determine the roles of proinflammatory cytokines in T cell activation in vivo and in the development of autoimmune disease, we have studied experimental autoimmune encephalomyelitis (EAE) in mice deficient in IL-6. We found that IL-6-deficient mice were completely resistant to EAE induced by myelin oligodendrocyte glycoprotein (MOG), whereas IL-6-competent control mice developed EAE characterized by focal inflammation and demyelination in the central nervous system and deficiency in neurologic functions. Furthermore, we established that the resistance to EAE in IL-6-deficient mice was associated with a deficiency of MOG-specific T cells to differentiate into either Th1 or Th2 type effector cells in vivo. These results strongly suggest that IL-6 plays a crucial role in the activation and differentiation of autoreactive T cells in vivo and that blocking IL-6 function can be an effective means to prevent EAE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis
Chen, Y., Kuchroo, V. K., Inobe, J.-I., Hafler, D. A., & Weiner, H. L. (1994) · Science · doi:10.1126/science.7520605 · Cited by 1,973
Self-citationImpaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · cited 6×
“Our observation that polyclonal T cell activation is normal in IL-6-deficient mice confirms earlier reports that immune response to mitogens in IL-6-deficient mice is comparable to that of normal mice (19, 20).”
BackgroundMethodResultInfluentialgp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Schwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293
Interleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272
Peripheral deletion of antigen-reactive T cells in oral tolerance
Chen, Y., Inobe, J.-I., Marks, R., Gonnella, P., Kuchroo, V. K., & Weiner, H. L. (1995) · Nature · doi:10.1038/376177a0 · Cited by 783
Self-citationIL-6 and APPs: anti-inflammatory and immunosuppressive mediators
Tilg, H., Dinarello, C. A., & Mier, J. W. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01103-1 · Cited by 633
Mendel, I., de Rosbo, N. K., & Ben‐Nun, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250723 · Cited by 601
Defective inflammatory response in interleukin 6-deficient mice.
Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P., & Poli, V (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1243 · Cited by 525
Interleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials
Gadient, R. A., & Otten, U. H. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00021-x · Cited by 481
The role of interleukin-6 in mucosal IgA antibody responses in vivo
Ramsay, A. J., Husband, A. J., Ramshaw, L. A., Bao, S., Matthaei, K. I., Koehler, G., & Kopf, M. (1994) · Science · doi:10.1126/science.8160012 · Cited by 454
Heyser, C. J., Masliah, E., Samimi, A., Campbell, I. L., & Gold, L. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1500 · Cited by 386
Interleukin‐6 Gene‐Deficient Mice Show Impaired Defense against Pneumococcal Pneumonia
van der Poll, T., Keogh, C. V., Guirao, X., Buurman, W. A., Kopf, M., & Lowry, S. F. (1997) · The Journal of Infectious Diseases · doi:10.1086/514062 · Cited by 382
Kerlero de Rosbo, N., Milo, R., Lees, M. B., Burger, D., Bernard, C. C., & Ben-Nun, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116875 · Cited by 325
Dalrymple, S. A., Lucian, L. A., Slattery, R., McNeil, T., Aud, D. M., Fuchino, S., Lee, F., & Murray, R. (1995) · Infection and Immunity · doi:10.1128/iai.63.6.2262-2268.1995 · Cited by 287
Dubey, C., Croft, M., & Swain, S. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.1.45 · Cited by 267
IL-6 rescues resting mouse T cells from apoptosis
Teague, T. K., Marrack, P., Kappler, J. W., & Vella, A. T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5791 · Cited by 248
Linington, C., & Lassmann, H. (1987) · Journal of Neuroimmunology · doi:10.1016/0165-5728(87)90031-2 · Cited by 221
Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection
Dalrymple, S. A., Slattery, R., Aud, D. M., Krishna, M., Lucian, L. A., & Murray, R. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3231-3235.1996 · Cited by 197
Issazadeh, S., Ljungdahl, A., Höjeberg, B., Mustafa, M., & Olsson, T. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00100-g · Cited by 173
Gijbels, K., Brocke, S., Abrams, J. S., & Steinman, L. (1995) · Molecular Medicine · doi:10.1007/bf03401894 · Cited by 156
Gijbels, K., Damme, J. V., Proost, P., Put, W., Carton, H., & Billiau, A. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200134 · Cited by 153
Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice
Suzuki, Y., Rani, S., Liesenfeld, O., Kojima, T., Lim, S., Nguyen, T. A., Dalrymple, S., Murray, R., & Remington, J. (1997) · Infection and Immunity · doi:10.1128/iai.65.6.2339-2345.1997 · Cited by 150
Immune Responses of IL‐4, IL‐5, IL‐6 Deficient Mice
Köpf, M., Gros, G. S. L., Coyle, A. J., Kosco‐Vilbois, M. H., Brombacher, F., & Köhler, G. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00093.x · Cited by 145
Taupin, V., Renno, T., Bourbonnière, L., Peterson, A. C., Rodriguez, M., & Owens, T. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270416 · Cited by 140
Regulation of an oligodendrocyte progenitor cell line by the interleukin‐6 family of cytokines
Kahn, M. A., & de Vellis, J. (1994) · Glia · doi:10.1002/glia.440120202 · Cited by 126
Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis.
Rodriguez, M., Pavelko, K. D., Mckinney, C., & Leibowitz, J. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.8.3811 · Cited by 113
Gajewski, T. F., Renauld, J., Pel, A. V., & Boon, T. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.5637 · Cited by 104
Yin, T., & Yang, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41921-1 · Cited by 99
Mendel, I., de Rosbo, N. K., & Ben‐Nun, A. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261030 · Cited by 96
Willenborg, D. O., Fordham, S. A., Cowden, W. B., & Ramshaw, I. A. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03530.x · Cited by 94
Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options
Hüll, M., Fiebich, B. L., Lieb, K., Strauss, S., Berger, M., Volk, B., & Bauer, J. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00107-8 · Cited by 82
Diab, A., Zhu, J., Xiao, B. G., Mustafa, M., & Link, H. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199706000-00002 · Cited by 77
Interleukin-6: A comprehensive review
Lotz, M. (1995) · Cancer treatment and research · doi:10.1007/978-1-4613-1241-3_8 · Cited by 74
Willenborg, D. O., Simmons, R. D., Tamatani, T., & Miyasaka, M. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90175-x · Cited by 72
Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids.
Moore, G. R. W., Traugott, U., Farooq, M., Norton, W. T., & Raine, C. S. (1984) · PubMed · Cited by 64
IL-6-mediated events in Alzheimer's disease pathology
Bauer, J., Strauss, S., Volk, B., & Berger, T. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90148-m · Cited by 61
Peripheral Blood Lymphocytes Respond Predominantly to Myelin Oligodendrocyte Glycoprotein
de Rosbo, N. K., Milo, R., Lees, M. B., et al. (1993) · Cited by 52
Holsti, M. A., McArthur, J. G., Allison, J. P., & Raulet, D. H. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1618 · Cited by 40
Nuclear signaling by interleukin-6
Chen‐Kiang, S., Hsu, W., Natkunam, Y., & Zhang, X. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90091-6 · Cited by 40
Vos, J. P., Gard, A. L., & Pfeiffer, S. E. (1996) · PubMed · Cited by 26
Cytokine Involvement in Central Nervous System Disease: Implications from Transgenic Micea
Campbell, I. L., & Chiang, C. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44690.x · Cited by 25
Cited by
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,848
Neuroinflammation: The Devil Is in the Details
DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640
Metadata
- Authors
- Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T.-S. T., & Chen, Y.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-12
- Volume
- 161
- Issue
- 12
- Pages
- 6480-6486
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1723158139
- Cited by
- 440
- References
- 43
- FWCI
- 9.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.